Dominique Costagliola

Impact of corticosteroids use on midterm sequelae in survivors of COVID‐19 admitted to hospital: A prospective cohort study

L. Bouadma, R. Borie, C. Cracowski, 2023, Journal of medical virology.

No time for complacency on COVID-19 in Europe

A. Flahault, H. Larson, H. Legido-Quigley, 2023, The Lancet.

The Human Immunodeficiency Virus Continuum of Care in European Union Countries in 2013: Data and Challenges

A. d’Arminio Monforte, C. Sabin, P. Reiss, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial

R. Greil, Y. Yazdanpanah, C. Marquette, 2021, The Lancet Infectious Diseases.

CD4:CD8 Ratio and CD8 Count as Prognostic Markers for Mortality in Human Immunodeficiency Virus–Infected Patients on Antiretroviral Therapy: The Antiretroviral Therapy Cohort Collaboration (ART-CC)

J. Sterne, P. Reiss, T. Sterling, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Remdesivir for the treatment of hospitalised patients with COVID-19: final results from the DisCoVeRy randomised, controlled, open-label trial

R. Greil, Y. Yazdanpanah, F. Raffi, 2022, medRxiv.

An open-label randomized, controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-beta-1a and hydroxychloroquine in hospitalized patients with COVID-19 - Final results from the DisCoVeRy trial

Y. Yazdanpanah, L. Bouadma, B. Mourvillier, 2022, medRxiv.

Rapid access to innovative medicinal products while ensuring relevant health technology assessment. Position of the French National Authority for Health

S. Chevret, B. Falissard, F. Naudet, 2023, BMJ evidence-based medicine.

Brentuximab vedotin with AVD for stage II-IV HIV-related Hodgkin lymphoma (AMC 085): phase 2 results from an open-label, single arm, multicentre phase 1/2 trial.

E. Cesarman, P. Moore, L. Ratner, 2023, The Lancet. Haematology.

A new SARS-CoV-2 variant with high lethality poorly detected by RT-PCR on nasopharyngeal samples: an observational study

B. Gagnière, P. Fillâtre, S. van der Werf, 2021, Clinical Microbiology and Infection.